Stories about Studie
- more
RESULTS OF THE MAIRE FOUNDATION STUDY AT COP29 IN BAKU: PEOPLE IN AZERBAIJAN AND KAZAKHSTAN AWARE OF THE URGENCY OF THE ENERGY TRANSITION
Milan/Baku (ots) - - 55% of Azerbaijani respondents say that the energy transition is a priority, in line with European countries - 64% of Azerbaijani respondents (more than the United Arab Emirates, Saudi Arabia and India) and 53% in Kazakhstan (more than Italy, the United Kingdom, the United States and China ...
moreGEMA files model action to clarify AI providers‘ remuneration obligations in Europe
moreGrünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
moreFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
moreTunisia's struggling economy puts democracy at risk, study finds
moreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
moreAcousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
moreNTT DATA Business Solutions AG
Latest Trend Study: Innovative Technologies are changing SAP© Application Management / Companies expect cost savings of up to 30 percent through AI
Bielefeld, Germany (ots) - - Increasing complexity of the IT landscape makes seamless integration and communication between SAP and non-SAP applications a central concern for respondents. - Cloud is the trend: Over 70 percent of the surveyed companies opt for the latest version of SAP S/4HANA, preferably in the ...
moreNext UK government must address 'long-term scars' of Brexit and austerity – study
moreNTT DATA Business Solutions AG
International study shows: companies underestimate the lead time and complexity of digital transformation projects
moreGermany Records Big Rise in Foreign Direct Investment in 2023
Berlin (ots) - The volume of international business expansions to and in Europe’s largest economy increased by over 37 percent last year. Germany attracted 34.8 billion euros worth of international business projects in 2023 – that’s the result of Germany Trade & Invest’s (GTAI) annual FDI study. The figure includes both greenfields and expansions. It does not include any mergers or acquisitions. The comparable ...
moreHow to halt democracy erosion
Gütersloh (ots) - The quality of democracy in developing and transformation countries has been in steady decline over the past 20 years. The latest findings of the Transformation Index of the Bertelsmann Stiftung, now in its tenth edition, show that out of 137 countries surveyed, only 63 remain democracies, while a majority are classified as autocracies. However, there is reason for hope. The examples of the transformation countries Brazil and Poland, where voters have ...
moreHearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...
moreThe Impact of Artificial Intelligence on the Willingness to Pay for Digital Newspaper Subscriptions - An Empirical Study of the German News Market
Hamburg (ots) - The prominence of Artificial Intelligence (AI) is steadily increasing, and its influence extends to various domains, including journalism. Within the realm of news reporting, numerous concepts and strategies are emerging to harness the potential of AI. However, readers are still very skeptical about ...
moreEUBP unveils the results of the 2023 Market Data Report
Berlin (ots) - European Bioplastics unveils the 2023 edition of the market development update during EBC23 taking place in Berlin, Germany. Main findings show that after a period of stagnation, the overall plastic production is picking up again. The global production for bioplastics is taking off after a few years of stagnation, induced by Covid-19 mainly. This development is driven by rising demand combined with the ...
moreHow can dual vocational education be transferred to other countries? Study provides answers
Gütersloh (ots) - Germany’s dual vocational training is considered a model of success - but how can it be transferred to other countries? Professor Dr. Dieter Euler answers this question in a new study "Roadmap to high-quality dual VET" commissioned by the Bertelsmann Stiftung. The German dual vocational education system is regarded as a success around the world – ...
moreAutomotive companies at the crossroads: Turning software-defined vehicles from hype to value driver
moreHearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
Tübingen, Germany (ots) - Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 — during four presentations at industry and research meetings from August 29 to September 5. From August 29–31, Acousia ...
moreEuropeans demand resolute action to counter internet disinformation
Gütersloh (ots) - More than half the EU population doubts the veracity of information on the web. Recognizing fake content and actively countering it comes more easily to those who are young and educated. Almost nine out of every 10 Europeans believe that tech companies, as well as government, should be held responsible. The population in the EU expects greater efforts in the battle against the deliberate dissemination ...
moreBirth weight and head circumference predict IQ and motor performance at 4 years of age
moreIn Gold We Trust Report 2023 "Showdown"
Schaan / Vienna (ots) - On May 24, 2023, this year's - now 17th - In Gold We Trust report was presented at an international press conference broadcast live on the Internet. The authors of the report are the two fund managers Ronald-Peter Stöferle and Mark J. Valek from the Liechtenstein-based asset manager Incrementum AG. The 400+ page In Gold We Trust report is renowned worldwide and has been dubbed the "gold standard ...
moreDEBIOPHARM ANNOUNCES LAUNCH OF THE PHASE 1/2 GaLuCiTM STUDY FOR ITS CA IX-TARGETED RADIOPHARMACEUTICAL PROGRAM
Lausanne, Switzerland (ots) - - Debiopharm is developing personalized radiotherapy through a theranostic approach, combining diagnostic imaging (Debio 0328 a gallium-labelled imaging tool) and therapeutic components (Debio 0228, a lutetium-labelled radioligand), thus allowing the pre-identification and treatment of ...
more- 2
Disruptions from Ransomware and Cyberattacks on Supply Chains and Critical Infrastructure Sharpen Focus on OT Security for 2023, TXOne Networks and Frost & Sullivan Analysis Reveals
more Yanfeng’s new XiM23 redefines luxury for future mobility
morebenfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
moreFood tech on its way to reshaping a multi trillion market
Berlin & New York (ots) - - Bain & ZINTINUS: “The food sector is at a tipping point, about to grow exponentially” - Transforming the global food sector to a more sustainable industry is important to improve consumer health and reduce the sector’s carbon footprint – it is also a means to secure food supply - The transition of the food system opens enormous opportunity for value creation and thus also for ...
morebenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
moreSpanish remains the most popular language to learn in the US, Lingoda research shows / Celebrating Spanish and English Language Day on April 23
moreTechSmith: New research shows the importance of using video at work
Okemos (ots) - Since the start of the global pandemic, the need for informal training videos for everyday use has expanded. A recent study conducted by TechSmith, which surveyed office workers from six countries, reveals that videos are highly popular among employees, especially in the modern workplaces where information needs to be conveyed concisely and efficiently. According to the study, the vast majority (83 percent) ...
more